Antibody candidate for treating serious liver disease
There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people…
February 7, 2023 - 4 minutes
In Depth
The biggest private biotech investments in January 2023
The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January…
February 6, 2023 - 4 minutes
News and Trends
Certa scleroderma study shows improvement in more than 60% of patients
Certa Therapeutics has announced what it says are ground-breaking clinical trial data for FT011, its…
February 7, 2023 - 5 minutes
News and Trends
Harvard spin-off cellvie closes $5.5M new funding
cellvie Inc., which works on therapeutic mitochondria transplantation (TMT), an approach developed at Harvard Medical…
February 7, 2023 - 2 minutes
What's New
MoreEvonetix closes $24M financing
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a…
February 7, 2023 - 2 minutes
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies…
February 7, 2023 - 3 minutes
AAHI bags $9.9M to develop nasal spray influenza RNA vaccine
The Access to Advanced Health Institute (AAHI) has been awarded a project agreement worth up…
February 7, 2023 - 3 minutes
Endogena Therapeutics retinitis pigmentosa treatment gets FDA fast track designation
The US Food and Drug Administration (FDA) has designated the investigation of Endogena Therapeutics’ EA-2353…
February 7, 2023 - 2 minutes
Sponsored
by WuXi Advanced Therapies
Streamlining CAR-T cell therapy manufacturing: a platform approach
Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that…
February 7, 2023 - 7 minutes
Beyond Biotech podcast 32: Cancer Research Horizons, Enterome, OncoHost, TrakCel, Turbine
Our guests are Ofer Sharon, CEO of OncoHost; Matthew Lakelin, co-founder, TrakCel; Pierre Belichard, CEO…
February 3, 2023 - 4 minutes
UK approval for AbbVie Crohn’s disease drug
AbbVie has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved…
February 3, 2023 - 3 minutes
AI and experiments: new possibilities emerge in 2023
By Markus Gershater, co-founder and chief scientific officer, Synthace The buzz surrounding generative AI has…
February 3, 2023 - 5 minutes
From Our Partners
View More
Sponsored
by WuXi Advanced Therapies
Streamlining CAR-T cell therapy manufacturing: a platform approach
Sponsored
by CENTOGENE
Improving rare disease diagnosis and treatment with next generation sequencing technology
Sponsored
by LINK Medical
How clinical trials benefit from decentralized solutions: A Nordic case study
Sponsored
by Crown Bioscience
Cancer cell line screening: a compass for drug discovery
Download our industry reports
View all our reports
